Literature DB >> 15970093

[Changes in pulmonary function in severe acute respiratory syndrome patients during convalescent period].

Ze-guang Zheng1, Rong-chang Chen, Hua Wu, Xiao-qing Liu, Wei-qun He, Yuan-da Xu, Si-bei Chen, Yi-min Li, Jin-ping Zheng, Nan-shan Zhong.   

Abstract

OBJECTIVE: To investigate the changes and pattern of pulmonary function in severe acute respiratory syndrome (SARS) patients during convalescent period.
METHODS: Pulmonary function tests were performed in 26 SARS convalescent patients regularly every 3 months after their discharge from hospital. The significance of changes in pulmonary function indexes was analyzed.
RESULTS: Restrictive pulmonary ventilation function and diffusing dysfunction of the lung were found in one third of the patients during third to sixth month from onset. There was a little improvement in forced vital capacity (FVC), one second forced expiratory volume (FEV(1.0)), functional residual capacity (FRC) and residual volume (RV) as convalescent period was prolonged, but no difference was found between different stages (3-6 months, 6-9 months, 9-12 months, 12-15 months and 15-17 months). Meanwhile, the FEV(1.0)/FVC showed no significant change. However, there was an obvious improvement in total lung capacity (TLC) and diffusing capacity of the lung for carbon monoxide (DLCO) with the elapse of time, and also a significant difference was found between the later stage and the earlier stage.
CONCLUSION: Pulmonary dysfunction is found among some SARS patients after convalescence presenting mainly as restrictive ventilatory function and diffusing capacity abnormality. These dysfunctions would improve gradually with the elapse of time.

Entities:  

Mesh:

Year:  2005        PMID: 15970093

Source DB:  PubMed          Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue        ISSN: 1003-0603


  4 in total

1.  Mild-to-moderate COVID-19 impact on the cardiorespiratory fitness in young and middle-aged populations.

Authors:  G D Back; M R Oliveira; P F Camargo; C L Goulart; C R Oliveira; K W Wende; J C Bonjorno Junior; R F Arbex; F R Caruso; R Arena; A Borghi-Silva
Journal:  Braz J Med Biol Res       Date:  2022-07-13       Impact factor: 2.904

2.  Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase.

Authors:  Yiying Huang; Cuiyan Tan; Jian Wu; Meizhu Chen; Zhenguo Wang; Liyun Luo; Xiaorong Zhou; Xinran Liu; Xiaoling Huang; Shican Yuan; Chaolin Chen; Fen Gao; Jin Huang; Hong Shan; Jing Liu
Journal:  Respir Res       Date:  2020-06-29

3.  Applying the WHO ICF Framework to the Outcome Measures Used in the Evaluation of Long-Term Clinical Outcomes in Coronavirus Outbreaks.

Authors:  Kajal Patel; Sofia Straudi; Ng Yee Sien; Nora Fayed; John L Melvin; Manoj Sivan
Journal:  Int J Environ Res Public Health       Date:  2020-09-05       Impact factor: 3.390

4.  Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis.

Authors:  Laura Fabbri; Samuel Moss; Fasihul A Khan; Wenjie Chi; Jun Xia; Karen Robinson; Alan Robert Smyth; Gisli Jenkins; Iain Stewart
Journal:  Thorax       Date:  2022-03-25       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.